Table III.
Details of the 4 groups categorized by antibody titres.
| Group | Patients, n | Age, years | Sex (% male) | Anti-HBc titres (S/CO) | Anti-HBs titres (mIU/ml) | Occurrence of HBV-R (%) | Time to HBV-R (days) | HBV-R/HF |
|---|---|---|---|---|---|---|---|---|
| ChighShigh | 9 | 76 (71–83) | 56 | 10.8 (10.1–12.9) | 254 (28.5–500) | 33.3 | 84 (21–190) | HBV-R |
| ChighSlow | 5 | 78 (73–81) | 60 | 16.2 (10.6–35) | 3.5 (0–6.7) | 40 | 51 (9–93) | HBV-R |
| ClowShigh | 40 | 73 (47–89) | 60 | 6.1 (0.07–10) | 358 (28.6–2990) | 0 | none | HBV-R |
| ClowSlow | 23 | 76 (62–83) | 61 | 6.4 (0.98–9.85) | 10.9 (0.2–27.5) | 21.7 | 322 (156–673) | HBV-R/HF |
ChighShigh, high anti-HBc titres and high anti-HBs titres; ChighSlow, high anti-HBc titres and low anti-HBs titres; ClowShigh, low anti-HBc titres and high anti-HBs titres; ClowSlow, low anti-HBc titres and low anti-HBs titres. HBc, hepatitis B core; HBs, hepatitis B surface; HBV-R, hepatitis B virus reactivation; HF, hepatitis flare. Age; sex; anti-HBc titres; anti-HBs titres and time to HBV-R indicate average values.